Association of angiopoietin-like protein 3 with hepatic triglyceride lipase and lipoprotein lipase activities in human plasma

Annals of Clinical Biochemistry

Volumn 47, Issue 5, 2010, Pages 423-431

  Nakajima, K ^a,b,c,d   Kobayashi, J ^a   Mabuchi, H ^a   Nakano, T ^b   Tokita, Y ^b   Nagamine, T ^b   Imamura, S ^e   Ai, M ^c   Otokozawa, S ^c   Schaefer, E F ^c  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c TUFTS UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e ASAHI KASEI PHARMA CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN LIKE PROTEIN 3; ENZYME INHIBITOR; LIPOPROTEIN; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; REMNANT LIPOPROTEIN CHOLESTEROL; REMNANT LIPOPROTEIN TRIGLYCERIDE; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; LIPOPROTEIN METABOLISM; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN FUNCTION; TRIACYLGLYCEROL BLOOD LEVEL;

ANGIOPOIETINS; FASTING; HUMANS; LIPASE; LIPOPROTEIN LIPASE; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LIVER; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; TRIGLYCERIDES;

EID: 77957674104     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/acb.2010.009307     Document Type: Article

References (38)

1. Koishi R, Ando Y, Ono M, et al. Angptl3 regulates lipid metabolism in mice. Nat Genet 2002;30:151-7
2. Shimizugawa T, Ono M, Shimamura M, et al. ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase. J Biol Chem 2002;277:33742-8
3. Fujimoto K, Koishi R, Shimizugawa T, Ando Y. Angptl3-null mice show low plasma lipid concentrations by enhanced lipoprotein lipase activity. Exp Anim 2006;55:27-34 (Pubitemid 43349428)
4. Ono M, Shimizugawa T, Shimamura M, et al. Protein region important for regulation of lipid metabolism in angiopoietin-like 3 (ANGPTL3): ANGPTL3 is cleaved and activated in vivo. J Biol Chem 2003;278:41804-9 (Pubitemid 37310440)
5. Shimamura M, Matsuda M, Yasumo H, et al. Angiopoietin-like protein3 regulates plasma HDL cholesterol through suppression of endothelial lipase. Arterioscler Thromb Vasc Biol 2007;27:366-72
6. Moon HD, Nakajima K, Kamiyama K, et al. Higher frequency of abnormal serum angiopoietin-like protein 3 than abnormal cholesteryl ester transfer protein in Japanese hyperalphalipoproteinemics. Clin Chim Acta 2008;398:93-104
7. Havel RJ. Remnant lipoproteins as therapeutic targets. Rev Curr Opin Lipidol 2000;11:615-20
8. Kobayashi J, Nakajima K, Nohara A, et al. The relationship of serum lipoprotein lipase mass with fasting serum apolipoprotein B-48 and remnant-like particle triglycerides in type 2 diabetic patients. Horm Metab Res 2007;39:612-16 (Pubitemid 47345237)
9. Dzien A, Breier C, Lisch HJ, Braunsteiner H. Stimulating effect of intermediate-density lipoproteins (IDL) from hyperlipemic plasma on hepatic lipase. Klin Wochenschr 1986;64:530-3 (Pubitemid 16055770)
10. Applebaum-Bowden D, Haffner SM, Hazzard WR. The dyslipoproteinemia of anabolic steroid therapy: increase in hepatic triglyceride lipase precedes the decrease in high density lipoprotein2 cholesterol. Metabolism 1987;36:949-52 (Pubitemid 17160512)
11. Kobayashi J, Kusunoki M, Murase Y, et al. Relationship of lipoprotein lipase and hepatic triacylglycerol lipase activity to serum adiponectin levels in Japanese hyperlipidemic men. Horm Metab Res 2005;37:505-9
12. Imamura S, Kobayashi J, Sakasegawa S, et al. A novel method for measuring human hepatic lipase activity in postheparin plasma. J Lipid Res 2007;48:453-7 (Pubitemid 46220612)
13. Imamura S, Kobayashi J, Nakajima K, et al. A novel method for measuring human lipoprotein lipase and hepatic lipase activities in postheparin plasma. J Lipid Res 2008;49:1431-7
14. Hirano T, Ito Y, Saegusa H, Yoshino G. A novel and simple method for quantification of small, dense LDL. J Lipid Res 2003;44:2193-201 (Pubitemid 37509635)
15. Stanhope KL, Schwarz JM, Keim NL, et al. Effects of consuming fructose- or glucose-sweetened beverages for 10 weeks on lipids, insulin sensitivity and adiposity. J Clin Invest 2009;119:1322-34
16. Mifflin MD, St Jeor ST, Hill LA, et al. A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr 1990;51:241-7
17. Nakajima K, Saito T, Tamura A, et al. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gel. Clin Chim Acta 1993;223:53-71
18. Babirak SP, Iverius PH, Fujimoto WY, Brunzell JD. Detection and characterization of the heterozygote state for lipoprotein lipase deficiency. Arteriosclerosis 1989;9:326-34
19. Tornvall P, Olivecrona G, Karpe F, Hamsten A, Olivecrona T. Lipoprotein lipase mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins. Arterioscler Thromb Vasc Biol 1995;15:1086-93
20. Totsuka M, Miyashita Y, Ito Y, Watanabe H, Murano T, Shirai K. Enhancement of preheparin serum lipoprotein lipase mass by bezafibrate administration. Atherosclerosis 2000;153:175-9
21. Kobayashi J, Nohara A, Kawashiri MA, et al. Serum lipoprotein lipase mass: clinical significance of its measurement. Clin Chim Acta 2007;378:7-12 (Pubitemid 46241085)
22. Pruneta-Deloche V, Sassolas A, Dallinga-Thie GM, Berthezène F, Ponsin G, Moulin P. Alteration in lipoprotein lipase activity bound to triglyceride-rich lipoproteins in the postprandial state in type 2 diabetes. J Lipid Res 2004;45:859-65 (Pubitemid 38552855)
23. Ong JM, Kirchgessner TG, Schotz MC, Kern PA. Insulin increases the synthetic rate and messenger RNA level of lipoprotein lipase in isolated rat adipocytes. J Biol Chem 1998;263:12933-8
24. Sadur CN, Eckel RH. Insulin stimulation of adipose tissue lipoprotein lipase. Use of the euglycemic clamp technique. J Clin Invest 1982;69:1119-25
25. Zambon A, Deeb SS, Pauletto P, Crepaldi G, Brunzell JD. Hepatic lipase: a marker for cardiovascular disease risk and response to therapy. Curr Opin Lipidol 2003;14:179-89 (Pubitemid 36521189)
26. Deeb SS, Zambon A, Carr MC, Ayyobi AF, Brunzell JD. Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet. J Lipid Res 2003;44:1279-86 (Pubitemid 37279608)
27. Oi K, Hirano T, Sakai S, Kawaguchi Y, Hosoya T. Role of hepatic lipase in intermediate-density lipoprotein and small, dense low-density lipoprotein formation in hemodialysis patients. Kidney Int Suppl 1999;71:S227-8
28. Murase T, Itakura H. Accumulation of intermediate density lipoprotein in plasma after intravenous administration of hepatic triglyceride lipase antibody in rats. Atherosclerosis 1981;39:293-300 (Pubitemid 11111320)
29. Austin MA, Breslow JL, Hennekens GH, et al. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988;260:1917-21
30. Deighan CJ, Caslake MJ, McConnell M, Boulton-Jones JM, Packard CJ. The atherogenic lipoprotein phenotype: small dense LDL and lipoprotein remnants in nephrotic range proteinuria. Atherosclerosis 2001;157:211-20 (Pubitemid 32539373)
31. Jin W, Wang X, Millar JS, et al. Hepatic proprotein convertases modulate HDL metabolism. Cell Metab 2007;6:129-36 (Pubitemid 47189092)
32. Ono M, Shimizugawa T, Shimamura M, et al. Protein region important for regulation of lipid metabolism on angiopoietin-like 3 (ANGPTL3). J Biol Chem 2003;278:41804-9
33. Yamashita S, Matsuzawa Y. Where are we with probucol: a new life for an old drug? Atherosclerosis 2009;207:16-23
34. Miida T, Seino U, Miyazaki O, et al. Probucol markedly reduces HDL phospholipids and elevated prebeta1-HDL without delayed conversion into alpha-migrating HDL: putative role of angiopoietin-like protein 3 in probucol-induced HDL remodeling. Atherosclerosis 2008;200:329-35
35. Homma Y, Moriguchi EH, Sakane H, et al. Effects of probucol on plasma lipoprotein subfractions and activities of lipoprotein lipase and hepatic triglyceride lipase. Atherosclerosis 1991;88:175-81
36. Favari E, Zanotti I, Zimetti F, et al. Probucol inhibits ABCA1-mediated cellular lipid efflux. Arterioscler Thromb Vasc Biol 2004;24:2345-50 (Pubitemid 39658040)
37. Kersten S, Mandard S, Tan NS, et al. Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. J Biol Chem 2000;275:284-90
38. Beigneux AP, Davies BS, Gin P, et al. Glycosylphosphatidylinositol- anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. Cell Metab 2007;5:279-91